Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China
Identifieur interne : 003468 ( Main/Exploration ); précédent : 003467; suivant : 003469Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China
Auteurs : Gang Wang [République populaire de Chine] ; Qi Cheng [République populaire de Chine] ; Rui Zheng [République populaire de Chine] ; Yu-Yan Tan [République populaire de Chine] ; Xiao-Kang Sun [République populaire de Chine] ; Hai-Yan Zhou [République populaire de Chine] ; Xiao-Lai Ye [République populaire de Chine] ; Ying Wang [République populaire de Chine] ; Zeng Wang [République populaire de Chine] ; Bo-Min Sun [République populaire de Chine] ; Sheng-Di Chen [République populaire de Chine]Source :
- Movement Disorders [ 0885-3185 ] ; 2006-09.
Descripteurs français
- Wicri :
- geographic : République populaire de Chine.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Ambulatory Care (economics), Antiparkinson Agents (economics), Antiparkinson Agents (therapeutic use), China, Combined Modality Therapy (economics), Cost of Illness, Costs and Cost Analysis (statistics & numerical data), Delivery of Health Care (economics), Developing Countries, Female, Health Care Costs (statistics & numerical data), Hoehn & Yahr stage, Humans, Levodopa (economics), Levodopa (therapeutic use), Male, Middle Aged, Parkinson Disease (drug therapy), Parkinson Disease (economics), Parkinson's disease, Patient Admission (economics), Patient Care Team (economics), Population Dynamics, Retrospective Studies, costs, resource use.
- MESH :
- chemical , economics : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- geographic : China.
- drug therapy : Parkinson Disease.
- economics : Ambulatory Care, Combined Modality Therapy, Delivery of Health Care, Parkinson Disease, Patient Admission, Patient Care Team.
- statistics & numerical data : Costs and Cost Analysis, Health Care Costs.
- Adult, Aged, Aged, 80 and over, Cost of Illness, Developing Countries, Female, Humans, Male, Middle Aged, Population Dynamics, Retrospective Studies.
Abstract
We investigated economic costs from patients with Parkinson's disease (PD) in Shanghai, China, which could be used as a baseline for future evaluations. Data were collected from 190 patients by interview during 1‐year period. Direct medical care costs averaged approximately Chinese yuan, renminbi (RMB) 4,305 (USD 519, or EUR 410) per year per patient, of which drugs (RMB 2,677) accounted for the major costly component. Nonmedical direct costs were much less than direct health care costs, averaging approximately RMB 3,301 (USD 398, or EUR 314). Costs due to loss of productivity averaged approximately RMB 73 (USD 8.8, or EUR 7.0) per patient per year. Taken together, the overall mean annual cost for PD in our series was approximately RMB 7,679 (USD 925, or EUR 731), and these costs accounted for around half of the mean annual income. Total cost was significantly associated with the disease severity and the frequency of outpatient visits. In addition, levodopa equivalent dose (LED) and the number of drugs being taken were also closely related with the drug cost. The results indicate that the economic burden of Chinese PD patients is heavy. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.20999
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001D97
- to stream Istex, to step Curation: 001D97
- to stream Istex, to step Checkpoint: 001F28
- to stream PubMed, to step Corpus: 002B95
- to stream PubMed, to step Curation: 002B95
- to stream PubMed, to step Checkpoint: 002D59
- to stream Ncbi, to step Merge: 001741
- to stream Ncbi, to step Curation: 001741
- to stream Ncbi, to step Checkpoint: 001741
- to stream Main, to step Merge: 004782
- to stream Main, to step Curation: 003468
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title>
<author><name sortKey="Wang, Gang" sort="Wang, Gang" uniqKey="Wang G" first="Gang" last="Wang">Gang Wang</name>
</author>
<author><name sortKey="Cheng, Qi" sort="Cheng, Qi" uniqKey="Cheng Q" first="Qi" last="Cheng">Qi Cheng</name>
</author>
<author><name sortKey="Zheng, Rui" sort="Zheng, Rui" uniqKey="Zheng R" first="Rui" last="Zheng">Rui Zheng</name>
</author>
<author><name sortKey="Tan, Yu An" sort="Tan, Yu An" uniqKey="Tan Y" first="Yu-Yan" last="Tan">Yu-Yan Tan</name>
</author>
<author><name sortKey="Sun, Xiao Ang" sort="Sun, Xiao Ang" uniqKey="Sun X" first="Xiao-Kang" last="Sun">Xiao-Kang Sun</name>
</author>
<author><name sortKey="Zhou, Hai An" sort="Zhou, Hai An" uniqKey="Zhou H" first="Hai-Yan" last="Zhou">Hai-Yan Zhou</name>
</author>
<author><name sortKey="Ye, Xiao Ai" sort="Ye, Xiao Ai" uniqKey="Ye X" first="Xiao-Lai" last="Ye">Xiao-Lai Ye</name>
</author>
<author><name sortKey="Wang, Ying" sort="Wang, Ying" uniqKey="Wang Y" first="Ying" last="Wang">Ying Wang</name>
</author>
<author><name sortKey="Wang, Zeng" sort="Wang, Zeng" uniqKey="Wang Z" first="Zeng" last="Wang">Zeng Wang</name>
</author>
<author><name sortKey="Sun, Bo In" sort="Sun, Bo In" uniqKey="Sun B" first="Bo-Min" last="Sun">Bo-Min Sun</name>
</author>
<author><name sortKey="Chen, Sheng I" sort="Chen, Sheng I" uniqKey="Chen S" first="Sheng-Di" last="Chen">Sheng-Di Chen</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/mds.20999</idno>
<idno type="url">https://api.istex.fr/document/CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001D97</idno>
<idno type="wicri:Area/Istex/Curation">001D97</idno>
<idno type="wicri:Area/Istex/Checkpoint">001F28</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Wang G:economic:burden:of</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16773620</idno>
<idno type="wicri:Area/PubMed/Corpus">002B95</idno>
<idno type="wicri:Area/PubMed/Curation">002B95</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002D59</idno>
<idno type="wicri:Area/Ncbi/Merge">001741</idno>
<idno type="wicri:Area/Ncbi/Curation">001741</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001741</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Wang G:economic:burden:of</idno>
<idno type="wicri:Area/Main/Merge">004782</idno>
<idno type="wicri:Area/Main/Curation">003468</idno>
<idno type="wicri:Area/Main/Exploration">003468</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China</title>
<author><name sortKey="Wang, Gang" sort="Wang, Gang" uniqKey="Wang G" first="Gang" last="Wang">Gang Wang</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cheng, Qi" sort="Cheng, Qi" uniqKey="Cheng Q" first="Qi" last="Cheng">Qi Cheng</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zheng, Rui" sort="Zheng, Rui" uniqKey="Zheng R" first="Rui" last="Zheng">Rui Zheng</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Tan, Yu An" sort="Tan, Yu An" uniqKey="Tan Y" first="Yu-Yan" last="Tan">Yu-Yan Tan</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sun, Xiao Ang" sort="Sun, Xiao Ang" uniqKey="Sun X" first="Xiao-Kang" last="Sun">Xiao-Kang Sun</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Zhou, Hai An" sort="Zhou, Hai An" uniqKey="Zhou H" first="Hai-Yan" last="Zhou">Hai-Yan Zhou</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Ye, Xiao Ai" sort="Ye, Xiao Ai" uniqKey="Ye X" first="Xiao-Lai" last="Ye">Xiao-Lai Ye</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Ying" sort="Wang, Ying" uniqKey="Wang Y" first="Ying" last="Wang">Ying Wang</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Wang, Zeng" sort="Wang, Zeng" uniqKey="Wang Z" first="Zeng" last="Wang">Zeng Wang</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Sun, Bo In" sort="Sun, Bo In" uniqKey="Sun B" first="Bo-Min" last="Sun">Bo-Min Sun</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurosurgery, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chen, Sheng I" sort="Chen, Sheng I" uniqKey="Chen S" first="Sheng-Di" last="Chen">Sheng-Di Chen</name>
<affiliation wicri:level="1"><country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>Department of Neurology & Institute of Neurology, Ruijin Hospital affiliated to the Medical School of Shanghai Jiaotong University, Shanghai</wicri:regionArea>
<wicri:noRegion>Shanghai</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-09">2006-09</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">9</biblScope>
<biblScope unit="page" from="1439">1439</biblScope>
<biblScope unit="page" to="1443">1443</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2</idno>
<idno type="DOI">10.1002/mds.20999</idno>
<idno type="ArticleID">MDS20999</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Ambulatory Care (economics)</term>
<term>Antiparkinson Agents (economics)</term>
<term>Antiparkinson Agents (therapeutic use)</term>
<term>China</term>
<term>Combined Modality Therapy (economics)</term>
<term>Cost of Illness</term>
<term>Costs and Cost Analysis (statistics & numerical data)</term>
<term>Delivery of Health Care (economics)</term>
<term>Developing Countries</term>
<term>Female</term>
<term>Health Care Costs (statistics & numerical data)</term>
<term>Hoehn & Yahr stage</term>
<term>Humans</term>
<term>Levodopa (economics)</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (economics)</term>
<term>Parkinson's disease</term>
<term>Patient Admission (economics)</term>
<term>Patient Care Team (economics)</term>
<term>Population Dynamics</term>
<term>Retrospective Studies</term>
<term>costs</term>
<term>resource use</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>China</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Ambulatory Care</term>
<term>Combined Modality Therapy</term>
<term>Delivery of Health Care</term>
<term>Parkinson Disease</term>
<term>Patient Admission</term>
<term>Patient Care Team</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Costs and Cost Analysis</term>
<term>Health Care Costs</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Cost of Illness</term>
<term>Developing Countries</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Population Dynamics</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>République populaire de Chine</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We investigated economic costs from patients with Parkinson's disease (PD) in Shanghai, China, which could be used as a baseline for future evaluations. Data were collected from 190 patients by interview during 1‐year period. Direct medical care costs averaged approximately Chinese yuan, renminbi (RMB) 4,305 (USD 519, or EUR 410) per year per patient, of which drugs (RMB 2,677) accounted for the major costly component. Nonmedical direct costs were much less than direct health care costs, averaging approximately RMB 3,301 (USD 398, or EUR 314). Costs due to loss of productivity averaged approximately RMB 73 (USD 8.8, or EUR 7.0) per patient per year. Taken together, the overall mean annual cost for PD in our series was approximately RMB 7,679 (USD 925, or EUR 731), and these costs accounted for around half of the mean annual income. Total cost was significantly associated with the disease severity and the frequency of outpatient visits. In addition, levodopa equivalent dose (LED) and the number of drugs being taken were also closely related with the drug cost. The results indicate that the economic burden of Chinese PD patients is heavy. © 2006 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
</list>
<tree><country name="République populaire de Chine"><noRegion><name sortKey="Wang, Gang" sort="Wang, Gang" uniqKey="Wang G" first="Gang" last="Wang">Gang Wang</name>
</noRegion>
<name sortKey="Chen, Sheng I" sort="Chen, Sheng I" uniqKey="Chen S" first="Sheng-Di" last="Chen">Sheng-Di Chen</name>
<name sortKey="Cheng, Qi" sort="Cheng, Qi" uniqKey="Cheng Q" first="Qi" last="Cheng">Qi Cheng</name>
<name sortKey="Sun, Bo In" sort="Sun, Bo In" uniqKey="Sun B" first="Bo-Min" last="Sun">Bo-Min Sun</name>
<name sortKey="Sun, Xiao Ang" sort="Sun, Xiao Ang" uniqKey="Sun X" first="Xiao-Kang" last="Sun">Xiao-Kang Sun</name>
<name sortKey="Tan, Yu An" sort="Tan, Yu An" uniqKey="Tan Y" first="Yu-Yan" last="Tan">Yu-Yan Tan</name>
<name sortKey="Wang, Ying" sort="Wang, Ying" uniqKey="Wang Y" first="Ying" last="Wang">Ying Wang</name>
<name sortKey="Wang, Zeng" sort="Wang, Zeng" uniqKey="Wang Z" first="Zeng" last="Wang">Zeng Wang</name>
<name sortKey="Ye, Xiao Ai" sort="Ye, Xiao Ai" uniqKey="Ye X" first="Xiao-Lai" last="Ye">Xiao-Lai Ye</name>
<name sortKey="Zheng, Rui" sort="Zheng, Rui" uniqKey="Zheng R" first="Rui" last="Zheng">Rui Zheng</name>
<name sortKey="Zhou, Hai An" sort="Zhou, Hai An" uniqKey="Zhou H" first="Hai-Yan" last="Zhou">Hai-Yan Zhou</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003468 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003468 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:CAB5D91625F86EA3AF87460165A4ACA5D19B1EB2 |texte= Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |